Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era

Hepatitis due to hepatitis B virus (HBV) reactivation can be serious and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell transpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Joyce Wing Yan, Law, Alvin Wing Hin, Law, Kimmy Wan Tung, Ho, Rita, Cheung, Carmen Ka Man, Law, Man Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507505/
https://www.ncbi.nlm.nih.gov/pubmed/37731995
http://dx.doi.org/10.3748/wjg.v29.i33.4942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507505/
https://www.ncbi.nlm.nih.gov/pubmed/37731995
http://dx.doi.org/10.3748/wjg.v29.i33.4942

Ejemplares similares